# Pfizer Personalized Medicine Dashboard â€“ Power BI Project

## ğŸ§¬ Project Overview

This project explores Pfizer's Personalized Medicine Initiative using clinical trial and genomic data to derive actionable insights that can drive **precision treatment strategies**. The Power BI dashboard visualizes patient demographics, genetic markers, drug response, and side effects to support personalized and safer drug development.

---

## ğŸ¯ Problem Statement

Most drug treatments follow a one-size-fits-all model, but not all patients respond the same way. This dashboard aims to:
- Analyze **patient demographics** (age, gender, ethnicity) impacting treatment
- Understand **genetic markers** affecting progression-free survival
- Identify **side effect patterns** by drug and demographic
- Recommend **dose optimization** based on age and response rates

---

## ğŸ“Š Dashboard Highlights

![Dashboard Screenshot](./Screenshot%202025-05-18%20102611.jpg)

- ğŸ“Œ **Success Rate by Gender & Age**: Females show a slightly higher success rate; age 18â€“30 group performs best.
- ğŸ’Š **Survival Rate by Drug**: Drug B performs highest (15.16), followed by Drug D.
- ğŸ§¬ **Mutation Status Analysis**: Positive genetic markers linked to higher survival.
- âš ï¸ **Side Effects by Drug**: Drug C shows highest side effect count.
- ğŸ“ˆ **Success by Trial Phase**: Phase II trials have the highest success rate (15.25).

---

## ğŸ›  Tools Used

| Tool       | Purpose                                |
|------------|----------------------------------------|
| Power BI   | Dashboard & interactive data visuals   |
| Excel      | Data cleaning and pre-processing       |

---

## ğŸ§  Insights Derived

- Age and gender impact treatment outcomes significantly.
- Genetic markers positively influence survival duration.
- Drug efficacy does not always correlate with side effect frequency.
- Trial Phase II appears to yield the most reliable results.

---

## ğŸ§  Conclusion:
The analysis highlights how clinical and genomic data can drive smarter, safer, and more personalized treatments.
 By identifying patterns across demographics, mutation status, and drug efficacy, this dashboard supports Pfizerâ€™s vision of data-driven healthcare. It proves that even small insights can lead to life-saving decisions â€” when backed by the power of data.


